Updates from The Motley Fool

Latest updates on Juno Therapeutics from Fool.com.

Stock Performance

JUNO vs. S&P 500 | 2 Year Performance
JUNO 1-Day Stock Chart
JUNO 5-Day Stock Chart
JUNO 1-Month Stock Chart
JUNO 3-Month Stock Chart
JUNO 6-Month Stock Chart
JUNO 1-Year Stock Chart
JUNO 2-Year Stock Chart
JUNO 5-Year Stock Chart
View Interactive JUNO Charts
Sponsored by

Key Data Points

Primary metrics and data points about Juno Therapeutics.
Current Price: $40.28
Prev Close: $40.38
Open: $40.59
Bid: $39.50
Ask: $40.20
Day's Range: $39.38 - $40.88
52wk Range: $22.37 - $69.28
Volume: 962,081
Avg Vol 814,361
Market Cap: $4.05B
P/E (ttm): -15.24
EPS (ttm): -$2.65
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Juno Therapeutics.
CAPS Rating 4 out of 5
149 Outperform
5 Underperform
CAPS All Stars
31 Outperform
4 Underperform

How do you think Juno Therapeutics will perform against the market?

You pick for Juno Therapeutics is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS

CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Hans Bishop, CEO

100% Approve

Based on 3 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Juno Therapeutics.


  • Exchange: NASDAQ